Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone)

  Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone) Dr. Sajad Zalzala is conducting very interesting trials on his patients utilizing Low Dose Naltrexone (LDN). He is collecting data on the various conditions LDN is helpful for, and what various dosages can be best in each case. His main area of […]

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (Abstract)

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (Abstract) Eur Heart J Cardiovasc Pharmacother 18 February 2022 https://pubmed.ncbi.nlm.nih.gov/35179184/ Coronavirus disease 2019 (COVID-19) is characterized by striking dysregulation of the immune system, with evidence of hyperinflammation, an impaired induction of interferons, and delayed adaptive immune responses. In addition to dysfunctional immune […]

Low-Dose Naltrexone Presents New Options for Patients with Inflammatory, Autoimmune Diseases (News)

Low-Dose Naltrexone Presents New Options for Patients with Inflammatory, Autoimmune Diseases Pharmacy Times 20 February 2022 https://www.pharmacytimes.com/view/low-dose-naltrexone-presents-new-options-for-patients-with-inflammatory-autoimmune-diseases In an interview at the Pharmacy Development Services 2022 conference, Sebastian Denison, RPh, BScPharm, said new developments are constantly being published for the use of low-dose naltrexone in patients with inflammatory and autoimmune diseases. Traditionally used for patients […]